1. McAuslane N, Anderson C, Walker S. The Changing Regulatory Environment:Reality and Perception. Epsom, UK: CMR International; 2004. R+D Briefing 42.
2. DiMasi J, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs.J Health Econ. 2003;22:151–185.
3. Similarities and Differences in Regulatory Approval Times. Profile of Performance (2). R&D Briefing 21. CMR International: 1999. Available at: http://www.cmr.org/pdf/rd21.pdf. Accessed December 14, 2005.
4. Rawson NSB. Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996–1998.Can Med Assoc J. 2000;162:501–504.
5. Rawson NSB, Kaitin KI. New drug approval times and "therapeutic potential" in Canada, Australia, Sweden and the United States during the period 1992 to 1998.Can J Clin Pharmacol. 2000;7:97–101.